– | Third Quarter Revenue of $44.3 Million, an Increase of 39% Year-Over-Year |
– | Gross Margin of 73.7% as Compared to 70.8% in the Year Ago Quarter |
– | Issues Revenue Guidance of $47.3 Million - $48.3 Million for the Fourth Quarter Fiscal 2018 |
– | Reaffirms Revenue Guidance of $169.5 Million - $170.5 Million for Fiscal 2018 |
• | Revenue of $44.3 million, a 39% increase as compared to the $31.9 million reported in third quarter fiscal 2017. The revenue increase was primarily due to the continued growth of our customer base and higher revenue from existing customers, primarily due to expanded subscriptions. |
• | Gross Profit of $32.7 million, a 45% increase as compared to the $22.6 million reported in third quarter fiscal 2017. Gross margin of 73.7% as compared to the 70.8% reported in third quarter fiscal 2017. |
• | Net Loss and Non-GAAP Net Loss: |
• | Net loss of $17.1 million as compared to the $10.2 million net loss in third quarter fiscal 2017. The increased loss was driven by increased operating expenses, primarily in sales and marketing, due to efforts to acquire new customers. |
• | Non-GAAP net loss of $11.1 million as compared to the $7.7 million non-GAAP net loss in the third quarter fiscal 2017. |
• | Net Loss Per Share and Non-GAAP Net Loss Per Share: |
• | Net loss per share of $0.19 based on 90.4 million weighted-average shares outstanding, compared to the net loss per share of $0.33 based on 31.1 million weighted-average shares outstanding in the third quarter fiscal 2017. |
• | Non-GAAP net loss per share of $0.12 based on 90.4 million weighted-average shares outstanding at quarter end, as compared to the $0.25 non-GAAP net loss per share in the third quarter fiscal 2017 based on 31.1 million weighted-average shares outstanding at quarter end. |
• | Readers are encouraged to review the tables labeled "Reconciliation of GAAP to Non-GAAP Financial Measures" at the end of this release. |
• | Balance Sheet: Cash, cash equivalents and marketable securities of $113.5 million as of October 31, 2017. |
• | Cash Flow: Cash used in operating activities for the third quarter of fiscal 2018 was $16.4 million as compared to cash used in operating activities of $9.0 million in the same period in fiscal 2017. The higher use of cash in the current period reflects a greater use from working capital, driven primarily by a higher balance in accounts receivable due to the timing of new business signed during the quarter. |
• | Managed approximately 27.1 million attributes through approximately 1.4 million licenses1 to Yext's digital knowledge platform as of October 31, 2017, representing increases of 66% and 58%, respectively, as compared to October 31, 2016. |
• | Announced the appointment of Tamar Yehoshua, Google's Vice President of Product Management for Search, to the Company's Board of Directors. |
• | Expanded the capabilities of the Yext App Directory through additional integrations with the world's leading business technologies, including Salesforce, StoreForce, Trabon, Radar, Dasheroo, Tiger Pistol and Hotfrog. The Yext App Directory allows customers to connect the digital knowledge they are managing within Yext to other software systems used across their enterprise. |
• | Expanded the global reach of the industry-leading PowerListings Network with new publishing partners in North America (Public Reputation, YellowPages.ca), South America (Paginas Amarillas), and Europe (golocal, Meinungsmeister), and enhanced the Reviews service by launching monitoring with TripAdvisor. |
• | Awarded a Best in Biz International Award (silver) for Enterprise Product of the Year in Software. |
• | Named one of the 100 Best Workplaces for Women by Great Place to Work® and Fortune Magazine. |
• | Fourth Quarter Fiscal 2018 Outlook: |
• | Revenue is projected to be $47.3 million to $48.3 million. |
• | Non-GAAP net loss per share is projected to be $0.10 to $0.12, which assumes 91.9 million weighted-average shares outstanding. |
• | Full Year Fiscal 2018 Outlook: |
• | Revenue is projected to be $169.5 million to $170.5 million. |
• | Non-GAAP net loss per share is projected to be $0.48 to $0.50, which assumes 93.2 million non-GAAP shares outstanding. |
• | Readers are encouraged to review the tables labeled "Reconciliation of GAAP to Non-GAAP Financial Measures" at the end of this release. |
October 31, 2017 | January 31, 2017 | ||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 21,112 | $ | 24,420 | |||
Marketable securities | 92,358 | — | |||||
Accounts receivable, net of allowances of $118 and $189, respectively | 23,861 | 27,646 | |||||
Prepaid expenses and other current assets | 5,551 | 3,511 | |||||
Deferred commissions | 6,633 | 6,252 | |||||
Total current assets | 149,515 | 61,829 | |||||
Restricted cash | — | 500 | |||||
Property and equipment, net | 11,496 | 11,613 | |||||
Goodwill | 4,701 | 4,444 | |||||
Intangible assets, net | 2,763 | 3,128 | |||||
Other long term assets | 3,442 | 4,951 | |||||
Total assets | $ | 171,917 | $ | 86,465 | |||
Liabilities, convertible preferred stock and stockholders’ equity (deficit) | |||||||
Current liabilities: | |||||||
Accounts payable, accrued expenses and other current liabilities | $ | 22,807 | $ | 25,633 | |||
Deferred revenue | 59,562 | 57,112 | |||||
Deferred rent | 1,271 | 936 | |||||
Total current liabilities | 83,640 | 83,681 | |||||
Deferred rent, non-current | 3,442 | 4,348 | |||||
Long term debt | — | 5,000 | |||||
Other long term liabilities | 710 | 576 | |||||
Total liabilities | 87,792 | 93,605 | |||||
Commitments and contingencies (Note 12) | |||||||
Convertible preferred stock: | |||||||
Convertible preferred stock, $0.001 par value per share; zero and 43,705,690 shares authorized at October 31, 2017 and January 31, 2017, respectively; zero and 43,594,753 shares issued and outstanding at October 31, 2017 and January 31, 2017, respectively | — | 120,615 | |||||
Stockholders’ equity (deficit): | |||||||
Preferred stock, $0.001 par value per share; 50,000,000 and zero shares authorized at October 31, 2017 and January 31, 2017, respectively; zero shares issued and outstanding at October 31, 2017 and January 31, 2017 | — | — | |||||
Common stock, $0.001 par value per share; 500,000,000 and 200,000,000 shares authorized at October 31, 2017 and January 31, 2017, respectively; 97,413,737 and 37,900,051 shares issued at October 31, 2017 and January 31, 2017, respectively; 90,908,403 and 31,394,717 shares outstanding at October 31, 2017 and January 31, 2017, respectively | 98 | 38 | |||||
Additional paid-in capital | 313,930 | 52,805 | |||||
Accumulated other comprehensive loss | (1,546 | ) | (1,808 | ) | |||
Accumulated deficit | (216,452 | ) | (166,885 | ) | |||
Treasury stock, at cost | (11,905 | ) | (11,905 | ) | |||
Total stockholders’ equity (deficit) | 84,125 | (127,755 | ) | ||||
Total liabilities, convertible preferred stock and stockholders’ equity (deficit) | $ | 171,917 | $ | 86,465 |
Three Months Ended October 31, | Nine Months Ended October 31, | ||||||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||||||
Revenue | $ | 44,332 | $ | 31,909 | $ | 122,181 | $ | 88,590 | |||||||
Cost of revenue | 11,658 | 9,324 | 31,887 | 27,226 | |||||||||||
Gross profit | 32,674 | 22,585 | 90,294 | 61,364 | |||||||||||
Operating expenses: | |||||||||||||||
Sales and marketing | 32,756 | 20,393 | 91,891 | 55,368 | |||||||||||
Research and development | 6,958 | 4,764 | 18,437 | 14,208 | |||||||||||
General and administrative | 10,196 | 7,548 | 29,103 | 20,222 | |||||||||||
Total operating expenses | 49,910 | 32,705 | 139,431 | 89,798 | |||||||||||
Loss from operations | (17,236 | ) | (10,120 | ) | (49,137 | ) | (28,434 | ) | |||||||
Investment income | 419 | 8 | 741 | 34 | |||||||||||
Interest expense | (104 | ) | (37 | ) | (274 | ) | (72 | ) | |||||||
Other expense, net | (132 | ) | (70 | ) | (667 | ) | (101 | ) | |||||||
Loss from operations before income taxes | (17,053 | ) | (10,219 | ) | (49,337 | ) | (28,573 | ) | |||||||
Provision for income taxes | (9 | ) | (3 | ) | (230 | ) | (4 | ) | |||||||
Net loss | $ | (17,062 | ) | $ | (10,222 | ) | (49,567 | ) | $ | (28,577 | ) | ||||
Net loss per share attributable to common stockholders, basic and diluted | $ | (0.19 | ) | $ | (0.33 | ) | $ | (0.67 | ) | $ | (0.92 | ) | |||
Weighted-average number of shares used in computing net loss per share attributable to common stockholders, basic and diluted | 90,353,608 | 31,092,270 | 73,992,705 | 31,031,276 | |||||||||||
Other comprehensive income (loss): | |||||||||||||||
Foreign currency translation adjustment | $ | 53 | $ | (347 | ) | $ | 410 | $ | (556 | ) | |||||
Unrealized loss on marketable securities | (88 | ) | — | (148 | ) | — | |||||||||
Total comprehensive loss | $ | (17,097 | ) | $ | (10,569 | ) | $ | (49,305 | ) | $ | (29,133 | ) |
Nine Months Ended October 31, | |||||||
2017 | 2016 | ||||||
Cash flows from operating activities: | |||||||
Net loss | $ | (49,567 | ) | $ | (28,577 | ) | |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
Depreciation and amortization | 3,751 | 2,949 | |||||
Provision for bad debts | 321 | 322 | |||||
Stock-based compensation expense | 15,002 | 6,316 | |||||
Change in fair value of convertible preferred stock warrant liability | 491 | 106 | |||||
Deferred income taxes | (13 | ) | (5 | ) | |||
Amortization of deferred financing costs | 105 | — | |||||
Amortization of premium on marketable securities | 108 | — | |||||
Gain on sale of marketable securities | (1 | ) | — | ||||
Changes in operating assets and liabilities: | |||||||
Restricted cash | 500 | 5,789 | |||||
Accounts receivable | 3,629 | 7,492 | |||||
Prepaid expenses and other current assets | (1,989 | ) | (2,156 | ) | |||
Deferred commissions | (1,152 | ) | (2,507 | ) | |||
Other long term assets | (161 | ) | (405 | ) | |||
Accounts payable, accrued expenses and other current liabilities | (2,625 | ) | 719 | ||||
Deferred revenue | 2,263 | 3,542 | |||||
Deferred rent | (581 | ) | (437 | ) | |||
Other long term liabilities | 89 | 14 | |||||
Net cash used in operating activities | (29,830 | ) | (6,838 | ) | |||
Cash flows from investing activities: | |||||||
Purchases of marketable securities | (106,155 | ) | — | ||||
Maturities of marketable securities | 7,500 | — | |||||
Sales of marketable securities | 6,041 | — | |||||
Capital expenditures | (2,747 | ) | (2,898 | ) | |||
Purchases of intangible assets | — | (298 | ) | ||||
Net cash used in investing activities | (95,361 | ) | (3,196 | ) | |||
Cash flows from financing activities: | |||||||
Proceeds from initial public offering, net of underwriting discounts and commissions | 123,527 | — | |||||
Payments of deferred offering costs | (4,263 | ) | — | ||||
Proceeds from exercise of stock options | 4,686 | 847 | |||||
Proceeds from exercise of warrants | 79 | — | |||||
Repayments on Revolving Line | (5,000 | ) | — | ||||
Payments of deferred financing costs | (99 | ) | — | ||||
Proceeds from employee stock purchase plan | 2,724 | — | |||||
Net cash provided by financing activities | 121,654 | 847 | |||||
Effect of exchange rate changes on cash and cash equivalents | 229 | (113 | ) | ||||
Net decrease in cash and cash equivalents | (3,308 | ) | (9,300 | ) | |||
Cash and cash equivalents at beginning of period | 24,420 | 30,028 | |||||
Cash and cash equivalents at end of period | $ | 21,112 | $ | 20,728 | |||
Supplemental disclosures of non-cash investing and financing information: | |||||||
Non-cash capital expenditures, including capitalized stock-based compensation, and items in accounts payable, accrued expenses and other current liabilities | $ | 451 | $ | 104 | |||
Conversion of convertible preferred stock to common stock | $ | 120,615 | $ | — | |||
Conversion of convertible preferred stock warrants to common stock warrants | $ | 1,435 | $ | — | |||
Cash paid on interest | $ | 71 | $ | 183 | |||
Cash paid on income taxes | $ | 983 | $ | 4 |
Three months ended October 31, 2017 | |||||||||||
GAAP | Stock-Based Compensation Expense | Non-GAAP | |||||||||
Cost and expenses: | |||||||||||
Cost of revenue | $ | 11,658 | $ | (461 | ) | $ | 11,197 | ||||
Gross profit | $ | 32,674 | $ | (461 | ) | $ | 33,135 | ||||
Sales and marketing | $ | 32,756 | $ | (2,741 | ) | $ | 30,015 | ||||
Research and development | $ | 6,958 | $ | (1,121 | ) | $ | 5,837 | ||||
General and administrative | $ | 10,196 | $ | (1,614 | ) | $ | 8,582 | ||||
Loss from operations | $ | (17,236 | ) | $ | (5,937 | ) | $ | (11,299 | ) | ||
Net loss | $ | (17,062 | ) | $ | (5,937 | ) | $ | (11,125 | ) |
Three months ended October 31, 2016 | |||||||||||
GAAP | Stock-Based Compensation Expense | Non-GAAP | |||||||||
Cost and expenses: | |||||||||||
Cost of revenue | $ | 9,324 | $ | (156 | ) | $ | 9,168 | ||||
Gross profit | $ | 22,585 | $ | (156 | ) | $ | 22,741 | ||||
Sales and marketing | $ | 20,393 | $ | (1,044 | ) | $ | 19,349 | ||||
Research and development | $ | 4,764 | $ | (508 | ) | $ | 4,256 | ||||
General and administrative | $ | 7,548 | $ | (809 | ) | $ | 6,739 | ||||
Loss from operations | $ | (10,120 | ) | $ | (2,517 | ) | $ | (7,603 | ) | ||
Net loss | $ | (10,222 | ) | $ | (2,517 | ) | $ | (7,705 | ) |
Nine months ended October 31, 2017 | |||||||||||
GAAP | Stock-Based Compensation Expense | Non-GAAP | |||||||||
Cost and expenses: | |||||||||||
Cost of revenue | $ | 31,887 | $ | (947 | ) | $ | 30,940 | ||||
Gross profit | $ | 90,294 | $ | (947 | ) | $ | 91,241 | ||||
Sales and marketing | $ | 91,891 | $ | (7,477 | ) | $ | 84,414 | ||||
Research and development | $ | 18,437 | $ | (2,433 | ) | $ | 16,004 | ||||
General and administrative | $ | 29,103 | $ | (4,145 | ) | $ | 24,958 | ||||
Loss from operations | $ | (49,137 | ) | $ | (15,002 | ) | $ | (34,135 | ) | ||
Net loss | $ | (49,567 | ) | $ | (15,002 | ) | $ | (34,565 | ) |
Nine months ended October 31, 2016 | |||||||||||
GAAP | Stock-Based Compensation Expense | Non-GAAP | |||||||||
Cost and expenses: | |||||||||||
Cost of revenue | $ | 27,226 | $ | (454 | ) | $ | 26,772 | ||||
Gross profit | $ | 61,364 | $ | (454 | ) | $ | 61,818 | ||||
Sales and marketing | $ | 55,368 | $ | (2,710 | ) | $ | 52,658 | ||||
Research and development | $ | 14,208 | $ | (1,397 | ) | $ | 12,811 | ||||
General and administrative | $ | 20,222 | $ | (1,755 | ) | $ | 18,467 | ||||
Loss from operations | $ | (28,434 | ) | $ | (6,316 | ) | $ | (22,118 | ) | ||
Net loss | $ | (28,577 | ) | $ | (6,316 | ) | $ | (22,261 | ) |
Three months ended October 31, | |||||||
2017 | 2016 | ||||||
Net loss | $ | (17,062 | ) | $ | (10,222 | ) | |
Stock-based compensation expense | 5,937 | 2,517 | |||||
Non-GAAP net loss | $ | (11,125 | ) | $ | (7,705 | ) | |
Net loss per share attributable to common stockholders, basic and diluted | $ | (0.19 | ) | $ | (0.33 | ) | |
Stock-based compensation expense per share | 0.07 | 0.08 | |||||
Non-GAAP net loss per share attributable to common stockholders, basic and diluted | $ | (0.12 | ) | $ | (0.25 | ) | |
Weighted-average number of shares used in computing net loss per share attributable to common stockholders, basic and diluted | 90,353,608 | 31,092,270 |
Nine Months Ended October 31, | |||||||
2017 | 2016 | ||||||
Net loss | $ | (49,567 | ) | $ | (28,577 | ) | |
Stock-based compensation expense | 15,002 | 6,316 | |||||
Non-GAAP net loss | $ | (34,565 | ) | $ | (22,261 | ) | |
Net loss per share attributable to common stockholders, basic and diluted | $ | (0.67 | ) | $ | (0.92 | ) | |
Stock-based compensation expense per share | 0.20 | 0.20 | |||||
Non-GAAP unweighted adjustment | 0.09 | — | |||||
Non-GAAP net loss per share attributable to common stockholders, basic and diluted | $ | (0.38 | ) | $ | (0.72 | ) | |
Weighted-average number of shares used in computing net loss per share attributable to common stockholders, basic and diluted | 73,992,705 | 31,031,276 | |||||
Non-GAAP unweighted adjustment | 16,915,698 | 78,937 | |||||
Non-GAAP number of shares outstanding in computing non-GAAP net loss per share attributable to common stockholders, basic and diluted | 90,908,403 | 31,110,213 |
Three months ended October 31, | |||||||
2017 | 2016 | ||||||
Net cash (used in) provided by: | |||||||
Net loss | $ | (17,062 | ) | $ | (10,222 | ) | |
Adjustments to net loss for non-cash items | 7,535 | 3,685 | |||||
Changes in operating assets and liabilities | (6,854 | ) | (2,494 | ) | |||
Operating activities | (16,381 | ) | (9,031 | ) | |||
Investing activities | 971 | (1,261 | ) | ||||
Financing activities | 3,692 | 336 | |||||
Effect of exchange rate changes on cash and cash equivalents | (49 | ) | (24 | ) | |||
Net decrease in cash and cash equivalents | (11,767 | ) | (9,980 | ) | |||
Cash and cash equivalents at beginning of period | 32,879 | 30,708 | |||||
Cash and cash equivalents at end of period | $ | 21,112 | $ | 20,728 |